1. Pedersen TR, Berg K, Cook TJ, et al. Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study. Arch Intern Med. 1996; 156:2085–2092. PMID:
8862101.
Article
2. Sinzinger H, Staudenherz A, Haber P, Berent R. The myth of muscle uptake of Tc-99m bisphosphonate in bone scan because of rhabdomyolysis. Nucl Med Commun. 2016; 37:1334–1336. PMID:
27776041.
Article
3. Huerta-Alardín AL, Varon J, Marik PE. Bench-to-bedside review: rhabdomyolysis -- an overview for clinicians. Crit Care. 2005; 9:158–169. PMID:
15774072.
4. Esnault VL, Nakhla M, Delcroix C, Moutel MG, Couturier O. What is the value of Tc-99m hydroxymethylene diphosphonate scintigraphy for the etiological diagnosis of mild rhabdomyolysis? Clin Nucl Med. 2007; 32:519–523. PMID:
17581334.
Article